Axel Capital Management’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-24,000
Closed -$1.44M 34
2018
Q2
$1.44M Hold
24,000
1.34% 24
2018
Q1
$1.57M Hold
24,000
1.39% 7
2017
Q4
$1.74M Hold
24,000
1.71% 11
2017
Q3
$1.85M Hold
24,000
1.22% 13
2017
Q2
$1.88M Hold
24,000
0.92% 12
2017
Q1
$1.99M Hold
24,000
1.45% 7
2016
Q4
$1.99M Hold
24,000
1.57% 7
2016
Q3
$1.94M Hold
24,000
1.49% 7
2016
Q2
$2M Hold
24,000
1.77% 7
2016
Q1
$2.02M Hold
24,000
1.07% 5
2015
Q4
$2.04M Hold
24,000
1.17% 7
2015
Q3
$1.99M Sell
24,000
-20,700
-46% -$1.87M 1.22% 8
2015
Q2
$3.77M Buy
44,700
+8,000
+22% +$690K 2.65% 4
2015
Q1
$3.11M Hold
36,700
2.18% 5
2014
Q4
$2.8M Hold
36,700
2.74% 7
2014
Q3
$2.17M Buy
36,700
+10,000
+37% +$656K 2.17% 10
2014
Q2
$1.98M Buy
26,700
+26,000
+3,714% +$1.82M 3.63% 5
2014
Q1
$46K Hold
700
0.1% 30
2013
Q4
$40K Hold
700
0.18% 21
2013
Q3
$31K Hold
700
0.81% 14
2013
Q2
$31K Buy
+700
New +$34.1K 3.87% 14

Other funds holding WBA

Axel Capital Management's WBA Position: Q3 2018 in Review

Axel Capital Management sold out of Walgreens Boots Alliance (WBA) in Q3 2018, closing a stake of 24,000 shares — an estimated $1.44M sold.

Axel Capital Management first reported a position in WBA in Q2 2013 and held it in 21 quarters. The position peaked at $3.77M in Q2 2015. 1,322 funds tracked by Wall St. Rank hold WBA as of Q3 2018.

  • Axel Capital Management reported no remaining Walgreens Boots Alliance position as of Q3 2018 after selling out during the quarter.
  • Axel Capital Management sold 24,000 Walgreens Boots Alliance shares in Q3 2018, an estimated $1.44M.
  • Axel Capital Management first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 21 quarters.
  • Axel Capital Management's Walgreens Boots Alliance position peaked at $3.77M in Q2 2015.
  • 1,322 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2018.

Based on Axel Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.